NCT05426668View on ClinicalTrials.gov

"Validation of the TheraSure CNI-Monitor Under Immuno-checkpoint-therapy (hereinafter: immunotherapy) in NSCLC in Palliative Therapy"

Not yet recruitingOBSERVATIONAL
Enrollment

170

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

November 30, 2027

Study Completion Date

February 29, 2028

Conditions
NSCLC
Interventions
OTHER

No Intervention

No Intervention

Trial Locations (2)

26121

Pius-Hospital Oldenburg, Oldenburg

30625

Medizinische Hochschule Hannover, Hanover

Sponsors
All Listed Sponsors
collaborator

Chronix Biomedical Corporation

INDUSTRY

lead

Karsten Gavenis

OTHER